Accepted at 1:57 a.m. Nov, 01, 2023 by Alex
Author: vmd13
Related Note: 1497200296622
Rationale for change

Improved grammar and clarity

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#AMBOSS::hw0ciR #AK_Step1_v12::^Other::^EXPN #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::12_Antimetabolites::*Purine_Synthesis_Inhibitors::Azathioprine #AK_Step1_v12::#Physeo::09_Pharm::01_Immunology::05_Azathioprine_&_6_MP #AK_Step1_v12::#Bootcamp::Immunology::13_Transplant_Rejection::07_Immunosuppressants #AK_Step1_v12::#OME::PreClinical::Immunology #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#B&B::11_Hematology::04_Cancer_Drugs::01_Antimetabolites #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::08_Cancer_therapy-cell_cycle #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Genetics::01_DNA_Structure::03_Clinical_Applications_of_the_Purine_Pathway #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::04_Azathioprine/6-MP #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::01_Antimetabolites::02_Azathioprine,_6-mercaptopurine,_Mycophenolate_Mofetil::zanki_extra #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::10_Cell_Cycle_Dependent_Drug_Targets !AK_UpdateTags::AnKing_Image::Ian::Cell_Cycle_Targets !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::01_Immunosuppressants::*Azathioprine